Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JHU-083 selectively blocks glutaminase activity in brain CD11b+ cells and prevents depression-associated behaviors induced by chronic social defeat stress
Xiaolei Zhu, Michael T. Nedelcovych, Ajit G. Thomas, et al.
Neuropsychopharmacology (2018) Vol. 44, Iss. 4, pp. 683-694
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion
Robert D. Leone, Liang Zhao, Judson M. Englert, et al.
Science (2019) Vol. 366, Iss. 6468, pp. 1013-1021
Open Access | Times Cited: 873
Microglia reprogram metabolic profiles for phenotype and function changes in central nervous system
Sheng Yang, Chuan Qin, Zi-Wei Hu, et al.
Neurobiology of Disease (2021) Vol. 152, pp. 105290-105290
Open Access | Times Cited: 142
Dectin-1 signaling on colonic γδ T cells promotes psychosocial stress responses
Xiaolei Zhu, Shinji Sakamoto, Chiharu Ishii, et al.
Nature Immunology (2023) Vol. 24, Iss. 4, pp. 625-636
Open Access | Times Cited: 56
Glutaminase 1 Regulates Neuroinflammation After Cerebral Ischemia Through Enhancing Microglial Activation and Pro-Inflammatory Exosome Release
Ge Gao, Congcong Li, Jie Zhu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 72
Glutamine Antagonist Synergizes with Electrodynamic Therapy to Induce Tumor Regression and Systemic Antitumor Immunity
Gui Chen, Qing Xu, Zhenzhen Feng, et al.
ACS Nano (2022) Vol. 16, Iss. 1, pp. 951-962
Closed Access | Times Cited: 69
Astrocyte-derived extracellular vesicles: A double-edged sword in central nervous system disorders
Shu Zhao, Shiyang Sheng, Yi Wang, et al.
Neuroscience & Biobehavioral Reviews (2021) Vol. 125, pp. 148-159
Open Access | Times Cited: 65
Microglial phagocytosis and regulatory mechanisms after stroke
Weijie Chen, Yueman Zhang, Xiaozhu Zhai, et al.
Journal of Cerebral Blood Flow & Metabolism (2022) Vol. 42, Iss. 9, pp. 1579-1596
Open Access | Times Cited: 46
Disruptions in cellular communication: Molecular interplay between glutamate/NMDA signalling and MAPK pathways in neurological disorders
Sumedha Gupta, Abhishek Gupta, Sidharth Mehan, et al.
Neuroscience (2025)
Closed Access | Times Cited: 1
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
Sunag Udupa, Stephanie A. Nguyen, Giang Hoang, et al.
PROTEOMICS (2019) Vol. 19, Iss. 21-22
Open Access | Times Cited: 60
Orally bioavailable glutamine antagonist prodrug JHU-083 penetrates mouse brain and suppresses the growth of MYC-driven medulloblastoma
Allison R. Hanaford, Jesse Alt, Rana Rais, et al.
Translational Oncology (2019) Vol. 12, Iss. 10, pp. 1314-1322
Open Access | Times Cited: 59
Glutaminase in microglia: A novel regulator of neuroinflammation
Lu Ding, Xiaonan Xu, Congcong Li, et al.
Brain Behavior and Immunity (2020) Vol. 92, pp. 139-156
Open Access | Times Cited: 59
Microglial glutaminase 1 deficiency mitigates neuroinflammation associated depression
Chenhui Ji, Yalin Tang, Yanyan Zhang, et al.
Brain Behavior and Immunity (2021) Vol. 99, pp. 231-245
Open Access | Times Cited: 45
An enriched environment improves long-term functional outcomes in mice after intracerebral hemorrhage by mechanisms that involve the Nrf2/BDNF/glutaminase pathway
Peijun Jia, Junmin Wang, Xiuhua Ren, et al.
Journal of Cerebral Blood Flow & Metabolism (2023) Vol. 43, Iss. 5, pp. 694-711
Open Access | Times Cited: 22
The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling
Alex Shimura Yamashita, Marina da Costa Rosa, Vittorio Stumpo, et al.
Neuro-Oncology Advances (2020) Vol. 3, Iss. 1
Open Access | Times Cited: 42
Inflamed brain: Targeting immune changes and inflammation for treatment of depression
Shinji Sakamoto, Xiaolei Zhu, Yuto Hasegawa, et al.
Psychiatry and Clinical Neurosciences (2021) Vol. 75, Iss. 10, pp. 304-311
Open Access | Times Cited: 41
Targeting Glutamine Metabolism Ameliorates Autoimmune Hepatitis via Inhibiting T Cell Activation and Differentiation
Qiang Yu, Honghu Tu, Xueyi Yin, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Dendrimer-2PMPA selectively blocks upregulated microglial GCPII activity and improves cognition in a mouse model of multiple sclerosis
Kristen R. Hollinger, Anjali Sharma, Carolyn Tallon, et al.
Nanotheranostics (2021) Vol. 6, Iss. 2, pp. 126-142
Open Access | Times Cited: 29
Glutamine metabolism inhibition has dual immunomodulatory and antibacterial activities against Mycobacterium tuberculosis
Sadiya Parveen, Jessica Shen, Shichun Lun, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13
Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders
Michael T. Nedelcovych, Boe-Hyun Kim, Xiaolei Zhu, et al.
Journal of Neuroimmune Pharmacology (2019) Vol. 14, Iss. 3, pp. 391-400
Open Access | Times Cited: 35
Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis
Carolyn Tallon, Anjali Sharma, Zhi Zhang, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 1, pp. 274-288
Open Access | Times Cited: 18
Microglia activation in the mPFC mediates anxiety‐like behaviors caused by Staphylococcus aureus strain USA300
Jiao Zou, Weilong Shang, Ling Yang, et al.
Brain and Behavior (2022) Vol. 12, Iss. 9
Open Access | Times Cited: 17
α-ketoglutarate (aKG) is a circulatory exercise factor that promotes learning and memory recall and has antidepressant properties.
Fady Eid, Perla El Ahmad, Reine Khoury, et al.
Biological Psychiatry Global Open Science (2025), pp. 100477-100477
Open Access
MRI demonstrates glutamine antagonist-mediated reversal of cerebral malaria pathology in mice
Brittany A. Riggle, Sanhita Sinharay, William Schreiber-Stainthorp, et al.
Proceedings of the National Academy of Sciences (2018) Vol. 115, Iss. 51
Open Access | Times Cited: 31
Novel Glutamine Antagonist JHU395 Suppresses MYC-Driven Medulloblastoma Growth and Induces Apoptosis
Khoa Pham, Micah J. Maxwell, Heather Sweeney, et al.
Journal of Neuropathology & Experimental Neurology (2021) Vol. 80, Iss. 4, pp. 336-344
Open Access | Times Cited: 21
Neutral sphingomyelinase 2 inhibition attenuates extracellular vesicle release and improves neurobehavioral deficits in murine HIV
Xiaolei Zhu, Kristen R. Hollinger, Yiyao Huang, et al.
Neurobiology of Disease (2022) Vol. 169, pp. 105734-105734
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top